SOURCE: Envita Medical Center

Envita Medical Center

July 28, 2015 18:35 ET

Envita Medical Center and Dr. Dino Prato: Could Biofilm Be the Reason We See Failures With Antibiotics in Chronic Lyme Disease Patients?

SCOTTSDALE, AZ--(Marketwired - July 28, 2015) - The prevalence and recognition of Lyme disease in America has grown substantially over the last decade. Antibiotics, either in oral or intravenous form, are the most common prescriptions used for the treatment of Lyme disease, but Envita Medical Center has found that this treatment alone is often ineffective for chronic Lyme disease sufferers. The possible answer to why some chronic Lyme disease patients are not getting better could be related to the presence of biofilm communities and exposure to multiple infections. This is because groundbreaking research from scientists at home and abroad shows that biofilm communities (described as any group of micro-organisms whose cells stick or adhere to each other on a surface) may be protecting Lyme disease and other co-infections from full spectrum antibiotic therapy effectiveness. In response, Envita Medical Center has implemented new, essential treatment strategies aimed at addressing antibiotic treatment failures in Lyme disease patients.

The reason why biofilm can cause antibiotic resistance, according to Medscape is that, “The biofilm matrix can act as a barrier to delay the diffusion of antibiotics into biofilms because antibiotics may either react chemically with biofilm matrix components or attach to anionic polysaccharides.” The theory behind this is that biofilm grows slowly, and as a rule antibiotics attack faster growing infections, allowing for the protection and survival of Lyme disease even after antibiotics are administered.

Biofilm can be quite the problem when it comes to infections. According to Dr. Dino Prato, “It is estimated that 80% of all human infections have biofilm involvement. Clinically, it’s important to address the buildup of biofilm in order for patients to receive the proper treatment they need to attack the mounting neurological and physical ailments that are associated with chronic Lyme disease.”

Because of the overwhelming information showing the existence and complications that come from biofilm (Eva Sapi’s work at the University of New Haven being another prime example), the new treatment strategy at Envita aims to strip biofilm while also penetrating intracellularly at the same time. It is important to add that these matrix colonies are found in higher concentration in areas where scar tissue and old injuries have accumulated. Envita Medical points out that even though various enzymes are commonly used to strip biofilm by integrative practitioners, they are insufficient alone.

To learn more about biofilm and how it may be impacting your treatment, view Envita’s page devoted to the issue at: www.envita.com.

Image Available: http://www.marketwire.com/library/MwGo/2015/7/28/11G049031/Images/bio_thumbs_logo-183335934556.jpg

Embedded Video Available: https://www.youtube.com/watch?v=FusiQtOYYIk

Contact Information